MedTrace Logo

PANDA: PKU Amino Acid Evaluation

NCT04086511 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2023-06-02

No results posted yet for this study

Summary

Phenylketonuria (PKU) is a rare inherited metabolic disorder, where subjects are born with a genetic deficiency in the phenylalanine hydroxylase enzyme (PAH), which leaves them unable to convert Phenylalanine (Phe) into Tyrosine (Tyr). PKU patients have specific dietary needs and must follow a restrictive diet in the aim of preventing toxic levels of the amino acid phenylalanine (Phe) accumulation.

Conditions

  • Phenylketonuria (PKU)

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Principal Investigators

  • Dr. P. Verloo · UZ Gent, Belgium

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2022-12-21
Completion
2023-04-14

Countries

  • Belgium
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04086511 on ClinicalTrials.gov